$PTGX develops peptide-based medicines, including candidates for rare endocrine and hematologic conditions. Its chart is narrowing into a falling wedge. Swing

$PTGX develops peptide-based medicines, including candidates for rare endocrine and hematologic conditions. Its chart is narrowing into a falling wedge. Swing highs declined from $160.81 to $151.24 while the more recent low rose from $130.63 to $141.95, bringing the boundaries together. Price has r…